Clinical Utility of Left Atrial Asynchrony and Mechanical Function in Patients with Hypertrophic Cardiomyopathy

Ozkan Candan1, Cetin Gecmen2, Muzaffer Kahyaoğlu2

  • 1Cardiology Clinic, Usak University, Faculty of Medicine, Usak.

Insights

In hypertrophic cardiomyopathy patients, increased atrial dispersion and reduced peak atrial longitudinal strain predict atrial fibrillation development. Age is also a key predictor, highlighting the importance of these echocardiographic measures for risk assessment.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Hypertrophic cardiomyopathy (HCM) is a significant risk factor for cardiovascular complications.
  • Atrial fibrillation (AF) is a common complication in HCM patients, increasing morbidity and mortality.
  • Predictive markers for AF development in HCM are crucial for timely intervention.

Purpose of the Study:

  • To investigate left atrial dispersion and strain using speckle tracking echocardiography as predictors of AF in HCM patients.
  • To assess the role of clinical parameters alongside echocardiographic findings in predicting AF development.

Main Methods:

  • A cohort of 151 HCM patients underwent comprehensive clinical and speckle tracking echocardiographic assessments.
  • Atrial dispersion was quantified as the standard deviation of time to peak strain in 12 left atrial segments.
  • AF development was monitored via electrocardiograms and Holter recordings during follow-up.

Main Results:

  • 26% of patients developed AF during follow-up.
  • Lower peak atrial longitudinal strain and higher atrial dispersion were significantly associated with AF development.
  • Multivariate analysis identified atrial dispersion, peak atrial longitudinal strain, and age as independent predictors of AF.

Conclusions:

  • Atrial dispersion and peak atrial longitudinal strain are significant predictors of AF in patients with hypertrophic cardiomyopathy.
  • Speckle tracking echocardiography-derived atrial dispersion offers valuable insights into left atrial function in HCM.
  • These echocardiographic parameters can aid in stratifying AF risk in HCM patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
52
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
40
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
65
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
71
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
46